Positive GLI1/INHBA feedback loop drives tumor progression in gastric cancer

被引:4
|
作者
Sun, Jingguo [1 ,2 ]
Zhu, Wenshuai [2 ]
Luan, Muhua [1 ]
Xing, Yuanxin [1 ,2 ]
Feng, Zhaotian [2 ]
Zhu, Jingyu [3 ]
Ma, Xiaoli [1 ,2 ]
Wang, Yunshan [1 ,2 ]
Jia, Yanfei [1 ,2 ,4 ]
机构
[1] Shandong Univ, Jinan Cent Hosp, Res Ctr Basic Med, Jinan, Peoples R China
[2] Shandong First Med Univ, Cent Hosp, Res Ctr Basic Med, Jinan, Peoples R China
[3] Shandong First Med Univ, Cent Hosp, Dept Gastroenterol, Jinan, Peoples R China
[4] Jinan Cent Hosp, Res Ctr Basic Med, 56 Shanda South Rd, Jinan 250013, Shandong, Peoples R China
关键词
gastric cancer; GLI1; INHBA; m6A; progression; GROWTH-FACTOR-BETA; PROSTATE-CANCER; EXPRESSION; GLI1; PROMOTES;
D O I
10.1111/cas.16193
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
GLI1, a key transcription factor of the Hedgehog (Hh) signaling pathway, plays an important role in the development of cancer. However, the function and mechanisms by which GLI1 regulates gene transcription are not fully understood in gastric cancer (GC). Here, we found that GLI1 induced the proliferation and metastasis of GC cells, accompanied by transcriptional upregulation of INHBA. This increased INHBA expression exerted a promoting activity on Smads signaling and then transcriptionally activated GLI1 expression. Notably, our results demonstrate that disrupting the interaction between GLI1 and INHBA could inhibit GC tumorigenesis in vivo. More intriguingly, we confirmed the N6-methyladenosine (m6A) activation mechanism of the Helicobacter pylori/FTO/YTHDF2/GLI1 pathway in GC cells. In conclusion, our study confirmed that the GLI1/INHBA positive feedback loop influences GC progression and revealed the mechanism by which H. pylori upregulates GLI1 expression through m6A modification. This positive GLI1/INHBA feedback loop suggests a novel noncanonical mechanism of GLI1 activity in GC and provides potential therapeutic targets for GC treatment.
引用
收藏
页码:2301 / 2317
页数:17
相关论文
共 50 条
  • [41] Hedgehog Pathway and GLI1 Isoforms in Human Cancer
    Carpenter, Richard L.
    Lo, Hui-Wen
    DISCOVERY MEDICINE, 2012, 13 (69) : 105 - 113
  • [42] Identification of GLI1 antagonists for breast cancer therapy
    Oladapo, Helen
    Fleming, Jodie M.
    Addo, Kezia
    Tarpley, Mike
    Ehe, Ben
    Ingram, Shalonda
    Sauer, Scott
    Devi, Gayathri
    Williams, Kevin P.
    CANCER RESEARCH, 2015, 75
  • [43] USP49 mediates tumor progression and poor prognosis through a YAP1-dependent feedback loop in gastric cancer
    Liu, Zhen
    Li, Junhe
    Ding, Yun
    Ma, Mei
    Chen, Jun
    Lei, Wan
    Li, Li
    Yao, Yangyang
    Yu, Xin
    Zhong, Min
    Liao, Quan
    Fang, Weidan
    Fan, Linwei
    Huang, Chunye
    Zhong, Hongguang
    Wen, Qin
    Fang, Zi
    Chen, Jingyi
    Huang, Shanshan
    Xiong, Jianpin
    Xiang, Xiaojun
    Deng, Jun
    ONCOGENE, 2022, 41 (18) : 2555 - 2570
  • [44] USP49 mediates tumor progression and poor prognosis through a YAP1-dependent feedback loop in gastric cancer
    Zhen Liu
    Junhe Li
    Yun Ding
    Mei Ma
    Jun Chen
    Wan Lei
    Li Li
    Yangyang Yao
    Xin Yu
    Min Zhong
    Quan Liao
    Weidan Fang
    Linwei Fan
    Chunye Huang
    Hongguang Zhong
    Qin Wen
    Zi Fang
    Jingyi Chen
    Shanshan Huang
    Jianpin Xiong
    Xiaojun Xiang
    Jun Deng
    Oncogene, 2022, 41 : 2555 - 2570
  • [45] MALAT1 functions as a transcriptional promoter of MALAT1::GLI1 fusion for truncated GLI1 protein expression in cancer
    Taiji Hamada
    Michiyo Higashi
    Seiya Yokoyama
    Toshiaki Akahane
    Masanori Hisaoka
    Hirotsugu Noguchi
    Tatsuhiko Furukawa
    Akihide Tanimoto
    BMC Cancer, 23
  • [46] LATS1 exerts tumor suppressor functions via targeting Gli1 in colorectal cancer
    Shen, Zhengchao
    Pan, Yingying
    Chen, Peng
    Jiang, Bin
    Fang, Xiaosan
    Jiang, Yaqi
    JOURNAL OF CANCER, 2021, 12 (24): : 7311 - 7319
  • [47] MALAT1 functions as a transcriptional promoter of MALAT1::GLI1 fusion for truncated GLI1 protein expression in cancer
    Hamada, Taiji
    Higashi, Michiyo
    Yokoyama, Seiya
    Akahane, Toshiaki
    Hisaoka, Masanori
    Noguchi, Hirotsugu
    Furukawa, Tatsuhiko
    Tanimoto, Akihide
    BMC CANCER, 2023, 23 (01)
  • [48] Expression of Gli1 and Wnt2B correlates with progression and clinical outcome of pancreatic cancer
    Jiang, Hua
    Li, Fengru
    He, Chengzhi
    Wang, Xuebin
    Li, Qingqing
    Gao, Hengjun
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (07): : 4531 - 4538
  • [49] Correction to: DLX6-AS1/miR-204-5p/OCT1 positive feedback loop promotes tumor progression and epithelial–mesenchymal transition in gastric cancer
    Yu Liang
    Chun-Dong Zhang
    Cheng Zhang
    Dong-Qiu Dai
    Gastric Cancer, 2022, 25 : 297 - 298
  • [50] The miR-532-E2F1 feedback loop contributes to gastric cancer progression
    Gao, Shanting
    Bu, Xiaomin
    Gao, Yongyue
    Bao, Zengtao
    Shi, Wenchao
    Luan, Lipeng
    Chen, Huiyu
    Zhang, Baoming
    Tian, Qingshui
    Guan, Wenxian
    Yang, Liuqing
    CELL DEATH & DISEASE, 2022, 13 (04)